z-logo
open-access-imgOpen Access
Older High-Risk MDS Patients Should Be Offered Curative Transplant
Author(s) -
Mark L. Fuerst
Publication year - 2021
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000735176.39826.8e
Subject(s) - medicine , transplantation , medicaid , myelodysplastic syndromes , hematopoietic stem cell transplantation , hematopoietic cell , quality of life (healthcare) , pediatrics , stem cell , intensive care medicine , haematopoiesis , health care , bone marrow , nursing , biology , economics , genetics , economic growth

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom